Related Experiment Video
Updated: Jun 17, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.
Daniel A Pollyea1, Jessica K Altman2, Rita Assi3
11University of Colorado Cancer Center.
Summary
This summary details updated guidelines for adult acute myeloid leukemia (AML) management. It focuses on monitoring and treating measurable residual disease to improve patient outcomes.
Area of Science:
- Hematology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a common and fatal adult leukemia.
- Current treatment advances necessitate guideline updates.
Purpose of the Study:
- To summarize recent NCCN Guidelines Panel recommendations for adult AML.
- To outline strategies for monitoring and managing measurable residual disease (MRD).
Main Methods:
- Review of recently published clinical trials in AML.
- Annual convening of the NCCN Guidelines Panel for AML.
Main Results:
- Updated recommendations for AML diagnosis and treatment.
- Focus on prognostic importance of biologic factors.
- Strategies for monitoring and managing measurable (minimal) residual disease.
Conclusions:
- Regular guideline updates are crucial for optimal AML patient care.
- Monitoring and managing MRD are key components of modern AML treatment.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...